M&A Deal Summary |
|
---|---|
Date | 2022-11-21 |
Target | Snapdragon Chemistry |
Sector | Chemicals |
Buyer(s) | Cambrex |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1981 |
Sector | Life Science |
Employees | 1,228 |
Revenue | 534M USD (2017) |
Cambrex is a life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapeutics. Cambrex was formed in 1981 and is headquartered in East Rutherford, New Jersey.
DEAL STATS | # |
---|---|
Overall | 7 of 7 |
Sector (Chemicals) | 1 of 1 |
Type (Add-on Acquisition) | 6 of 6 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 4 of 4 |
Year (2022) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-01 |
Q1 Scientific
Waterford, Ireland Q1 Scientific is a provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device, and life science industries. Q1 Scientific was founded in 2013 and is based in Waterford, Ireland. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-11-02 |
Cambrex Drug Product- Business Unit
Whippany, New Jersey, United States Cambrex Drug Product's Business Unit is a technology-focused contract manufacturing business with differentiated applications and capabilities in solid, semi-solid and liquid dosage forms, with a particular focus on controlled substances. Cambrex Drug Product's Business Unit was established in 2006 and is based in Whippany, New Jersey. |
Sell | - |